SEND 3.1- Standard for the Exchange of Nonclinical Data

With over 125 billion data points delivered in the SEND format, Covance is a partner who can help you efficiently prepare and analyze your data points in the SEND format to gain the most insights. Covance continues to be a leader in the development of SEND, including being an active contributor in the SEND Consortium and the FDA / PhUSE working groups. 

  • Streamline your FDA submission process – avoid potential delays in development

  • Version 3.1 ready as of February 2019

  • Over 1400 submission-ready studies delivered in the SEND format

SEND education center
Your Needs

Achieve compliant and secure FDA submissions. With new FDA requirements which took effect on December 17, 2016, you need to be able to receive and submit nonclinical study data in the SEND format for your toxicology studies. We can help you with any SEND requirements.

Imagine analyzing data from multiple studies, comparing data with historical controls, identifying trends and anomalies with ease, and then taking action. SEND makes it possible to share visual results with study stakeholders for improved communication.

You need to know that your SEND datasets are reliable and that your SEND process is going to work. Learn best practices from experts who know the SEND process. Reduce stress by getting ready early.

Our Capabilities

With Covance, you get a proven SEND partnership and process:

  • Covance is part of the CDISC SEND Consortium and FDA/PhUSE Working Groups that are developing SEND standards and terminology
  • Covance uses Pristima® software and Pinnacle 21 for high integrity. Open SEND.xpt data with SAS Viewer and easily save to spreadsheets. Receive files securely via FTP or Covance StudyTracker®
  • Covance successfully delivers SEND today with more than 125 billion data points and greater than 500 studies performed